-
Something wrong with this record ?
Innovative Approach in the Cryogenic Freezing Medium for Mesenchymal Stem Cells
N. Pilbauerova, J. Schmidt, T. Soukup, T. Prat, K. Nesporova, V. Velebny, J. Suchanek
Language English Country Switzerland
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Health & Medicine (ProQuest)
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
PubMed
35625538
DOI
10.3390/biom12050610
Knihovny.cz E-resources
- MeSH
- Dimethyl Sulfoxide * pharmacology MeSH
- Cryopreservation methods MeSH
- Cryoprotective Agents pharmacology MeSH
- Culture Media MeSH
- Humans MeSH
- Mesenchymal Stem Cells * MeSH
- Freezing MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
The physical stresses during cryopreservation affect stem cell survival and further proliferation. To minimize or prevent cryoinjury, cryoprotective agents (CPAs) are indispensable. Despite the widespread use of 10% dimethyl sulfoxide (DMSO), there are concerns about its potential adverse effects. To bypass those effects, combinations of CPAs have been investigated. This study aimed to verify whether high-molecular-hyaluronic acid (HMW-HA) serves as a cryoprotectant when preserving human mesenchymal stem cells (hMSCs) to reduce the DMSO concentration in the cryopreservation medium. We studied how 0.1% or 0.2% HMW-HA combined with reduced DMSO concentrations (from 10% to 5%, and 3%) affected total cell count, viability, immunophenotype, and differentiation potential post-cryopreservation. Immediately after cell revival, the highest total cell count was observed in 10% DMSO-stored hMSC. However, two weeks after cell cultivation an increased cell count was seen in the HMW-HA-stored groups along with a continued increase in hMSCs stored using 3% DMSO and 0.1% HMW-HA. The increased total cell count corresponded to elevated expression of stemness marker CD49f. The HA-supplemented cryomedium did not affect the differential potential of hMSC. Our results will participate in producing a ready-to-use product for cryopreservation of mesenchymal stem cells.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018741
- 003
- CZ-PrNML
- 005
- 20220804135049.0
- 007
- ta
- 008
- 220720s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/biom12050610 $2 doi
- 035 __
- $a (PubMed)35625538
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Pilbauerova, Nela $u Department of Dentistry, Charles University, Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Sokolska 581, 50005 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000306894546 $7 xx0214576
- 245 10
- $a Innovative Approach in the Cryogenic Freezing Medium for Mesenchymal Stem Cells / $c N. Pilbauerova, J. Schmidt, T. Soukup, T. Prat, K. Nesporova, V. Velebny, J. Suchanek
- 520 9_
- $a The physical stresses during cryopreservation affect stem cell survival and further proliferation. To minimize or prevent cryoinjury, cryoprotective agents (CPAs) are indispensable. Despite the widespread use of 10% dimethyl sulfoxide (DMSO), there are concerns about its potential adverse effects. To bypass those effects, combinations of CPAs have been investigated. This study aimed to verify whether high-molecular-hyaluronic acid (HMW-HA) serves as a cryoprotectant when preserving human mesenchymal stem cells (hMSCs) to reduce the DMSO concentration in the cryopreservation medium. We studied how 0.1% or 0.2% HMW-HA combined with reduced DMSO concentrations (from 10% to 5%, and 3%) affected total cell count, viability, immunophenotype, and differentiation potential post-cryopreservation. Immediately after cell revival, the highest total cell count was observed in 10% DMSO-stored hMSC. However, two weeks after cell cultivation an increased cell count was seen in the HMW-HA-stored groups along with a continued increase in hMSCs stored using 3% DMSO and 0.1% HMW-HA. The increased total cell count corresponded to elevated expression of stemness marker CD49f. The HA-supplemented cryomedium did not affect the differential potential of hMSC. Our results will participate in producing a ready-to-use product for cryopreservation of mesenchymal stem cells.
- 650 _2
- $a kryoprezervace $x metody $7 D015925
- 650 _2
- $a kryoprotektivní látky $x farmakologie $7 D003451
- 650 _2
- $a kultivační média $7 D003470
- 650 12
- $a dimethylsulfoxid $x farmakologie $7 D004121
- 650 _2
- $a zmrazování $7 D005615
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mezenchymální kmenové buňky $7 D059630
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Schmidt, Jan $u Department of Dentistry, Charles University, Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Sokolska 581, 50005 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000283997111
- 700 1_
- $a Soukup, Tomas $u Department of Histology and Embryology, Faculty of Medicine in Hradec Kralove, Charles University, Simkova 870, 50003 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000174755711 $7 xx0036274
- 700 1_
- $a Prat, Tomas $u Contipro a.s., Dolni Dobrouc 401, 56102 Dolni Dobrouc, Czech Republic $1 https://orcid.org/0000000181293383
- 700 1_
- $a Nesporova, Kristina $u Contipro a.s., Dolni Dobrouc 401, 56102 Dolni Dobrouc, Czech Republic $1 https://orcid.org/0000000178647689
- 700 1_
- $a Velebny, Vladimir $u Contipro a.s., Dolni Dobrouc 401, 56102 Dolni Dobrouc, Czech Republic
- 700 1_
- $a Suchanek, Jakub $u Department of Dentistry, Charles University, Faculty of Medicine in Hradec Kralove and University Hospital Hradec Kralove, Sokolska 581, 50005 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000238473802 $7 xx0143207
- 773 0_
- $w MED00188737 $t Biomolecules $x 2218-273X $g Roč. 12, č. 5 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35625538 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804135043 $b ABA008
- 999 __
- $a ok $b bmc $g 1822384 $s 1169984
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 12 $c 5 $e 20220420 $i 2218-273X $m Biomolecules $n Biomolecules $x MED00188737
- LZP __
- $a Pubmed-20220720